ANAB - AnaptysBio - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ANAB is currently covered by 7 analysts with an average price target of $41.25. This is a potential upside of $20.3 (96.9%) from yesterday's end of day stock price of $20.95.

AnaptysBio's activity chart (see below) currently has 78 price targets and 80 ratings on display. The stock rating distribution of ANAB is 9.09% SELL, 54.55% HOLD and 36.36% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50.15% with an average time for these price targets to be met of 239.42 days.

Highest price target for ANAB is $90, Lowest price target is $33, average price target is $41.25.

Most recent stock forecast was given by ANUPAM RAMA from JPMORGAN on 12-Nov-2024. First documented stock forecast 21-Feb-2017.

Currently out of the existing stock ratings of ANAB, 2 are a SELL (9.09%), 12 are a HOLD (54.55%), 8 are a BUY (36.36%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$66

$47 (247.37%)

$75

9 days ago
(12-Nov-2024)

7/11 (63.64%)

$44.35 (204.85%)

545

Hold

$33

$14 (73.68%)

$21

22 days ago
(30-Oct-2024)

4/10 (40%)

$10.82 (48.78%)

125

Buy

$90

$71 (373.68%)

$44

1 months ago
(21-Oct-2024)

2/8 (25%)

$54.63 (154.45%)

229

Buy

$42

$23 (121.05%)

$34

1 months 26 days ago
(26-Sep-2024)

11/17 (64.71%)

$9.65 (29.83%)

108

Buy

$50

$31 (163.16%)

$130

9 months ago
(21-Feb-2024)

0/2 (0%)

$24.51 (96.16%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ANAB (AnaptysBio) average time for price targets to be met?

On average it took 239.42 days on average for the stock forecasts to be realized with a an average price target met ratio 50.15

Which analyst has the current highest performing score on ANAB (AnaptysBio) with a proven track record?

YATIN SUNEJA

Which analyst has the most public recommendations on ANAB (AnaptysBio)?

Yatin Suneja works at GUGGENHEIM and has 9 price targets and 5 ratings on ANAB

Which analyst is the currently most bullish on ANAB (AnaptysBio)?

Kennen Mackay with highest potential upside - $117.54

Which analyst is the currently most reserved on ANAB (AnaptysBio)?

Biren Amin with lowest potential downside - -$7

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?